Page 107 - TBE_Book_V2_2019

Chapter 4: Pathogenesis of TBE

53. Zhang N, Zhang L. Key components of COPI and mild dengue disease. Clin Exp Immunol.
COPII machineries are required for 2006;143(2):345-356.
chikungunya virus replication. Biochem Biophys
Res Commun. 2017;493(3):1190-1196. 64. Larena M, Regner M, Lobigs M. Cytolytic
effector pathways and IFN-gamma help protect
54. Lindqvist R, Mundt F, Gilthorpe JD, et al. Fast against Japanese encephalitis. Eur J Immunol.
type I interferon response protects astrocytes 2013;43(7):1789-1798.
from flavivirus infection and virus-induced
cytopathic effects. J Neuroinflammation. 65. Strauss-Albee DM, Fukuyama J, Liang EC, et al.
2016;13(1):277. Human NK cell repertoire diversity reflects
immune experience and correlates with viral
55. Best SM, Morris KL, Shannon JG, et al. susceptibility. Sci Transl Med. 2015;7
Inhibition of interferon-stimulated JAK-STAT (297):297ra115.
signaling by a tick-borne flavivirus and
identification of NS5 as an interferon 66. Vargin VV, Semenov BF. Changes of natural
antagonist. J Virol. 2005;79(20):12828-12839. killer cell activity in different mouse lines by
acute and asymptomatic flavivirus infections.
56. Werme K, Wigerius M, Johansson M. Tick- Acta Virol. 1986;30(4):303-308.
borne encephalitis virus NS5 associates with
membrane protein scribble and impairs 67. Blom K, Braun M, Pakalniene J, et al. NK Cell
interferon-stimulated JAK-STAT signalling. Cell Responses to Human Tick-Borne Encephalitis
Microbiol. 2008;10(3):696-712. Virus Infection. J Immunol. 2016;197(7):2762-
2771.
57. Lubick KJ, Robertson SJ, McNally KL, et al.
Flavivirus Antagonism of Type I Interferon 68. Kawai T, Akira S. Innate immune recognition of
Signaling Reveals Prolidase as a Regulator of viral infection. Nat Immunol. 2006;7(2):131-
IFNAR1 Surface Expression. Cell Host Microbe. 137.
2015;18(1):61-74. 69. Palmer DR, Sun P, Celluzzi C, et al. Differential
effects of dengue virus on infected and
58. Avirutnan P, Fuchs A, Hauhart RE, et al.
Antagonism of the complement component C4 bystander dendritic cells. J Virol. 2005;79
by flavivirus nonstructural protein NS1. J Exp (4):2432-2439.
Med. 2010;207(4):793-806. 70. Qian F, Wang X, Zhang L, et al. Impaired
interferon signaling in dendritic cells from
59. Avirutnan P, Hauhart RE, Somnuke P, Blom AM,
Diamond MS, Atkinson JP. Binding of flavivirus older donors infected in vitro with West Nile
nonstructural protein NS1 to C4b binding virus. J Infect Dis. 2011;203(10):1415-1424.
protein modulates complement activation. J 71. Cao S, Li Y, Ye J, et al. Japanese encephalitis
Immunol. 2011;187(1):424-433. Virus wild strain infection suppresses dendritic
cells maturation and function, and causes the
60. Jacobs SC, Stephenson JR, Wilkinson GW.
expansion of regulatory T cells. Virol J.
Protection elicited by a replication-defective
2011;8:39.
adenovirus vector expressing the tick-borne
encephalitis virus non-structural glycoprotein 72. Robertson SJ, Lubick KJ, Freedman BA,
NS1. J Gen Virol. 1994;75 ( Pt 9):2399-2402. Carmody AB, Best SM. Tick-borne flaviviruses
antagonize both IRF-1 and type I IFN signaling
61. Jost S, Altfeld M. Control of human viral
to inhibit dendritic cell function. J Immunol.
infections by natural killer cells. Annu Rev
2014;192(6):2744-2755.
Immunol. 2013;31:163-194.
73. Pierson TC, Fremont DH, Kuhn RJ, Diamond
62. Dropulic LK, Cohen JI. Severe viral infections
MS. Structural insights into the mechanisms of
and primary immunodeficiencies. Clin Infect
antibody-mediated neutralization of flavivirus
Dis. 2011;53(9):897-909.
infection: implications for vaccine
63. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, development. Cell Host Microbe. 2008;4(3):229
Cerqueira DI, Nogueira RM, Kubelka CF. NK -238.
cells, displaying early activation, cytotoxicity
and adhesion molecules, are associated with
102